Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-30

Clinical Trial Update: Valsartan Intensified Primary Care Reduction of Blood Pressure Study [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating valsartan to intensify primary care for blood pressure reduction; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2012-08-30